These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15947349)

  • 1. Small cell carcinoma of the lung exclusively localized within the left descending pulmonary artery.
    Kamigaki M; Yamazaki K; Tsujino I; Suga M; Sakaue S; Dosaka-Akita H; Nishimura M
    Chest; 2005 Jun; 127(6):2273-6. PubMed ID: 15947349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staging and monitoring of small cell lung cancer using [18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET).
    Kut V; Spies W; Spies S; Gooding W; Argiris A
    Am J Clin Oncol; 2007 Feb; 30(1):45-50. PubMed ID: 17278894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique solitary small cell lung cancer: need for histologic examination.
    Faulkner S
    Chest; 2005 Jun; 127(6):1889. PubMed ID: 15947298
    [No Abstract]   [Full Text] [Related]  

  • 4. An unexpected abdominal 18F-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET) in a patient with limited stage small cell lung cancer.
    Decoster L; Stroobants S; Verbeken E; Nackaerts K; Vansteenkiste J
    J Thorac Oncol; 2008 Feb; 3(2):174-6. PubMed ID: 18303440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and evolving treatment options for limited stage small cell lung cancer.
    Lee CB; Morris DE; Fried DB; Socinski MA
    Curr Opin Oncol; 2006 Mar; 18(2):162-72. PubMed ID: 16462186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When is it best to repeat a 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan on patients with non-small cell lung cancer who have received neoadjuvant chemoradiotherapy?
    Cerfolio RJ; Bryant AS
    Ann Thorac Surg; 2007 Oct; 84(4):1092-7. PubMed ID: 17888953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-fluorodeoxyglucose positron emission tomography in small-cell lung cancer.
    Zhao DS; Valdivia AY; Li Y; Blaufox MD
    Semin Nucl Med; 2002 Oct; 32(4):272-5. PubMed ID: 12524651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-body (18)F-FDG PET improves the management of patients with small cell lung cancer.
    Kamel EM; Zwahlen D; Wyss MT; Stumpe KD; von Schulthess GK; Steinert HC
    J Nucl Med; 2003 Dec; 44(12):1911-7. PubMed ID: 14660716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of chest CT on the staging and re-staging in patients with small cell lung cancer].
    Eguchi K; Yamada K; Saijo N; Kaneko M; Naruke I; Matsno Y
    Rinsho Hoshasen; 1990 Jul; 35(7):821-4. PubMed ID: 2169552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a role for positron emission tomography/computed tomography in the staging of small-cell lung cancer?
    Truong MT; Marom EM
    Clin Lung Cancer; 2008 Jan; 9(1):8. PubMed ID: 18282351
    [No Abstract]   [Full Text] [Related]  

  • 11. Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53).
    Schild SE; Bonner JA; Hillman S; Kozelsky TF; Vigliotti AP; Marks RS; Graham DL; Soori GS; Kugler JW; Tenglin RC; Wender DB; Adjei A
    J Clin Oncol; 2007 Jul; 25(21):3124-9. PubMed ID: 17634491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic activity on [18f]-fluorodeoxyglucose-positron emission tomography/computed tomography and glucose transporter-1 expression might predict clinical outcomes in patients with limited disease small-cell lung cancer who receive concurrent chemoradiation.
    Lee J; Kim JO; Jung CK; Kim YS; Yoo IeR; Choi WH; Jeon EK; Hong SH; Chun SH; Kim SJ; Kim YK; Kang JH
    Clin Lung Cancer; 2014 Mar; 15(2):e13-21. PubMed ID: 24368212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
    Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings.
    Frank A; Lefkowitz D; Jaeger S; Gobar L; Sunderland J; Gupta N; Scott W; Mailliard J; Lynch H; Bishop J
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1495-512. PubMed ID: 7635795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Small cell lung cancer that appeared as a strange shape on chest X-ray films].
    Fujino S; Kohno N; Fujioka S; Hamada H; Inoue Y; Yokoyama A; Hiwada K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 May; 33(5):588-91. PubMed ID: 7609349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small cell lung cancer with tracheal obstruction.
    Le BH; Rosenthal MA
    Intern Med J; 2005 Aug; 35(8):490. PubMed ID: 16176474
    [No Abstract]   [Full Text] [Related]  

  • 17. Positron emission tomography in limited-stage small-cell lung cancer: a prospective study.
    Bradley JD; Dehdashti F; Mintun MA; Govindan R; Trinkaus K; Siegel BA
    J Clin Oncol; 2004 Aug; 22(16):3248-54. PubMed ID: 15310768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restaging of mediastinal nodes with transbronchial needle aspiration after induction chemoradiation for locally advanced non-small cell lung cancer.
    Kunst PW; Lee P; Paul MA; Senan S; Smit EF
    J Thorac Oncol; 2007 Oct; 2(10):912-5. PubMed ID: 17909353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between lung fibrosis and radiation therapy dose after concurrent radiation therapy and chemotherapy for limited small cell lung cancer.
    Rosen II; Fischer TA; Antolak JA; Starkschall G; Travis EL; Tucker SL; Hogstrom KR; Cox JD; Komaki R
    Radiology; 2001 Dec; 221(3):614-22. PubMed ID: 11719654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of irinotecan plus cisplatin induction followed by concurrent twice-daily thoracic irradiation with etoposide plus cisplatin chemotherapy for limited-disease small-cell lung cancer.
    Han JY; Cho KH; Lee DH; Kim HY; Kim EA; Lee SY; Lee JS
    J Clin Oncol; 2005 May; 23(15):3488-94. PubMed ID: 15908658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.